Certificate under Regulation 74(5) of the SEBI (Depositories & Participants) Regulation, 2018 for the quarter ended December 31, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Genpharmasec Ltd has submitted a compliance certificate from its Registrar and Share Transfer Agent, Satellite Corporate Services Pvt. Ltd., for the quarter ended December 31, 2025. The certificate confirms that no physical share certificates were received from shareholders for dematerialization during the quarter. The filing is a routine SEBI regulatory requirement under Regulation 74(5), which mandates RTAs to confirm the status of physical share certificates received for conversion into demat form. The certificate was signed by the company's Whole Time Director & CFO, Mr. Sohan Chaturvedi.
This is a standard quarterly compliance filing with no material impact on shareholders or stock price. It simply confirms that no physical-to-demat share conversions took place during the quarter, indicating that all shares are likely already in dematerialized form.